Literature DB >> 6193731

A new procedure for the synthesis of polyethylene glycol-protein adducts; effects on function, receptor recognition, and clearance of superoxide dismutase, lactoferrin, and alpha 2-macroglobulin.

C O Beauchamp, S L Gonias, D P Menapace, S V Pizzo.   

Abstract

A new, simplified technique for the synthesis of polyethylene glycol (PEG) derivatives of proteins utilizing 1,1'-carbonyldiimidazole for PEG activation, is described. PEG derivatives of superoxide dismutase, alpha 2-macroglobulin, alpha 2-macroglobulin-trypsin, and lactoferrin were prepared and studied. Superoxide dismutase coupled to PEG preserved 95% of its original activity while its plasma half-life increased from 3.5 min to 9 or more hours depending on the PEG derivative studied. PEG-derivatized alpha 2-macroglobulin showed decreased protease binding activity but PEG derivatives of performed alpha 2-macroglobulin-trypsin demonstrated no loss of activity. The plasma clearance of PEG-alpha 2-macroglobulin-trypsin was prolonged significantly compared to native alpha 2-macroglobulin-trypsin, particularly when a high-molecular-weight PEG was coupled to the protease inhibitor complex. The plasma clearance half-life of lactoferrin was increased 5- to 20-fold by this modification. Trinitrobenzenesulfonic acid titration studies demonstrated that epsilon-amino groups of lysine residues are modified by the coupling of carbonyldiimidazole-activated PEG to proteins.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6193731     DOI: 10.1016/0003-2697(83)90131-8

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  19 in total

1.  Effector-assisted refolding of recombinant tissue-plasminogen activator produced in Escherichia coli.

Authors:  H Grunfeld; A Patel; A Shatzman; A H Nishikawa
Journal:  Appl Biochem Biotechnol       Date:  1992-05       Impact factor: 2.926

Review 2.  Nanomedicine: clinical applications of polyethylene glycol conjugated proteins and drugs.

Authors:  Suphiya Parveen; Sanjeeb K Sahoo
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

3.  Luminescent Difluoroboron β-Diketonate PLA-PEG Nanoparticle.

Authors:  Caroline Kerr; Christopher A DeRosa; Margaret L Daly; Hengtao Zhang; Gregory M Palmer; Cassandra L Fraser
Journal:  Biomacromolecules       Date:  2017-02-02       Impact factor: 6.988

4.  Protein conjugation with amphiphilic block copolymers for enhanced cellular delivery.

Authors:  Xiang Yi; Elena Batrakova; William A Banks; Serguei Vinogradov; Alexander V Kabanov
Journal:  Bioconjug Chem       Date:  2008-04-16       Impact factor: 4.774

5.  Alpha 2-macroglobulin is the primary inhibitor of miniplasmin in vitro and in vivo in the mouse. Comparison with alpha 2-antiplasmin in simultaneous reaction experiments.

Authors:  S L Gonias; N L Figler
Journal:  Biochem J       Date:  1988-10-15       Impact factor: 3.857

6.  Chemical modification of recombinant interleukin 2 by polyethylene glycol increases its potency in the murine Meth A sarcoma model.

Authors:  N V Katre; M J Knauf; W J Laird
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

7.  Investigation of the biological effects of anti-cell adhesive synthetic peptides that inhibit experimental metastasis of B16-F10 murine melanoma cells.

Authors:  M J Humphries; K M Yamada; K Olden
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

Review 8.  Thermosensitive liposomes for localized delivery and triggered release of chemotherapy.

Authors:  Terence Ta; Tyrone M Porter
Journal:  J Control Release       Date:  2013-04-11       Impact factor: 9.776

9.  Antigenic peptides containing large PEG loops designed to extend out of the HLA-A2 binding site form stable complexes with class I major histocompatibility complex molecules.

Authors:  M Bouvier; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

10.  Evidence for role of hydroxyl radical in complement and neutrophil-dependent tissue injury.

Authors:  P A Ward; G O Till; R Kunkel; C Beauchamp
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.